Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease
Clinical trial NCT05663827 · COMPLETED
Trial details
- NCT number
- NCT05663827
- Sponsor
- Yi-Lun Wang
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2020-01-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.